Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331883 | SCV001524028 | uncertain significance | Developmental and epileptic encephalopathy, 25 | 2020-08-27 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Broad Center for Mendelian Genomics, |
RCV001331883 | SCV001999878 | uncertain significance | Developmental and epileptic encephalopathy, 25 | 2021-11-02 | criteria provided, single submitter | curation | The p.Phe552Ile variant in SLC13A5 has been reported in 1 homozygous individual with developmental and epileptic encephalopathy (PMID: 31054490) and has been identified in 0.005% (1/18394) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs1453393447). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 1030354) and has been interpreted as VUS by Baylor Genetics. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Phe552Ile variant is uncertain. ACMG/AMP Criteria applied: PM3_supporting, PM2_supporting (Richards 2015). |
Revvity Omics, |
RCV001331883 | SCV003823325 | uncertain significance | Developmental and epileptic encephalopathy, 25 | 2023-06-15 | criteria provided, single submitter | clinical testing |